Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Human artificial chromosome (HAC) vectors are an important gene transfer system for expression and complementation studies. We describe a significant advance in HAC technology using infectious herpes simplex virus type 1 (HSV‐1) amplicon vectors for delivery. This highly efficient method has allowed gene‐expressing HACs to be established in glioma‐, kidney‐ and lung‐derived cells. We also developed an HSV‐1 hypoxanthine phosphoribosyltransferase (HPRT) HAC vector, which generated functional HPRT‐expressing HACs that complemented the genetic deficiency in human cells. The transduction efficiency of the HSV‐1 HAC amplicons is several orders of magnitude higher than lipofection‐mediated delivery. Studies on HAC stability between cell types showed important differences that have implications for HAC development and gene expression in human cells. This is the first report of establishing gene‐expressing HACs in human cells by using an efficient, high‐capacity viral vector and by identifying factors that are involved in cell‐type‐specific HAC instability. The work is a significant advance for HAC technology and the development of HAC gene expression systems in human cells.

Original publication

DOI

10.1038/sj.embor.7400768

Type

Journal article

Journal

EMBO reports

Publisher

Springer Science and Business Media LLC

Publication Date

09/2006

Volume

7

Pages

911 - 918